CHICAGO--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) today announced the publication of the MASTER trial results in the peer-reviewed journal Anesthesia and Analgesia, demonstrating the safety and ...

The retrospective analysis of nearly 15,000 general anesthesia cases of adults (18 years and older) at the University of Michigan demonstrated End-tidal Control’s association with reduced anesthetic ...

GE HealthCare (Nasdaq: GEHC) today announced the presentation of findings from the largest real-world evidence study to-date on End-tidal Control anesthesia delivery* software conducted at the ...

Determined to reach net zero emissions by 2050, GE HealthCare’s portfolio features environmentally conscious product design, energy efficiency, and technology circularity while continuing to drive ...

CHICAGO--(BUSINESS WIRE)--As part of a companywide commitment to advance innovation that improves the health of patients and the planet, GE HealthCare (Nasdaq: GEHC) is highlighting several solutions ...